Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Saccharomyces Boulardii for H. Pylori Rescue Therapy
NCT05191875Completed
- Sponsor
- Third Xiangya Hospital, Central South University
- Start
- Dec 2021
- Primary completion
- Apr 2022
- Modality
- Microbiome Therapeutics
- Countries
- 1
01
Overview
Randomised, open-label trial of saccharomyces boulardii in Helicobacter pylori infection (2 arms), sponsored by Third Xiangya Hospital, Central South University. Primary endpoint: The eradication rate of H. pylori infection at Day 42. Started Dec 2021; status: completed.
02
Drugs
saccharomyces boulardii
03
Conditions
Helicobacter pylori infection
Beyond the preview
Go deeper on NCT05191875.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT05191875.